A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration

NATerminatedINTERVENTIONAL
Enrollment

7,053

Participants

Timeline

Start Date

December 18, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

April 30, 2017

Conditions
End Stage Renal Disease
Interventions
OTHER

Dialysis session of at least 4.25 hours

Facilities randomized to the Intervention arm will adopt the practice of recommending dialysis session durations of at least 4.25 hours for all patients initiating hemodialysis treatment regardless of body size or dialysis solute clearance measurements.

Trial Locations (2)

55404

DaVita Clinical Research, Minneapolis

02451

Fresenius Medical Care North America, Waltham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

National Institutes of Health (NIH)

NIH

collaborator

Fresenius Medical Care North America

INDUSTRY

collaborator

Davita Clinical Research

INDUSTRY

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Pennsylvania

OTHER

NCT02019225 - A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration | Biotech Hunter | Biotech Hunter